Middle East & Africa Hematuria Treatment Market
The Middle East & Africa Hematuria Treatment Market size was valued at US$ 42.0 Mn in 2021 and is projected to reach US$ 46.8 Mn by 2028, growing at a CAGR of 1.5% during 2021 - 2028.
Report Coverage
- Treatment: Drugs, Therapies
- Indication: Urinary Tract Infections, Kidney Stones, Urethritis, Blood Cancer, Bladder Stones, Prostate Cancer, Cystitis, Trauma, Vigorous Exercise, Polycystic Kidney Disease, Endometriosis, Menstruation
- Type: Macroscopic Hematuria, Microscopic Hematuria, Idiopathic Hematuria, Jogger's Hematuria
- End User: Hospitals, Clinics, Ambulatory Surgical Centers
US$ 42.0 Mn
Market size in 2021
US$ 46.8 Mn
Market Size by 2028
1.5%
CAGR, 2021 - 2028
2022-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa Hematuria Treatment Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa Hematuria Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa Hematuria Treatment Market Regional Analysis
6.2 Middle East & Africa Hematuria Treatment Market Revenue 2019-2028 (US$ Million)
6.3 Middle East & Africa Hematuria Treatment Market Forecast Analysis
7. Middle East & Africa Hematuria Treatment Market Analysis – by Treatment
7.1 Drugs
- 7.1.1 Overview
- 7.1.2 Drugs: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Therapies
- 7.2.1 Overview
- 7.2.2 Therapies: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Middle East & Africa Hematuria Treatment Market Analysis – by Indication
8.1 Urinary Tract Infections
- 8.1.1 Overview
- 8.1.2 Urinary Tract Infections: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Kidney Stones
- 8.2.1 Overview
- 8.2.2 Kidney Stones: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Urethritis
- 8.3.1 Overview
- 8.3.2 Urethritis: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Blood Cancer
- 8.4.1 Overview
- 8.4.2 Blood Cancer: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.5 Bladder Stones
- 8.5.1 Overview
- 8.5.2 Bladder Stones: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.6 Prostate Cancer
- 8.6.1 Overview
- 8.6.2 Prostate Cancer: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.7 Cystitis
- 8.7.1 Overview
- 8.7.2 Cystitis: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.8 Trauma
- 8.8.1 Overview
- 8.8.2 Trauma: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.9 Vigorous Exercise
- 8.9.1 Overview
- 8.9.2 Vigorous Exercise: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.10 Polycystic Kidney Disease
- 8.10.1 Overview
- 8.10.2 Polycystic Kidney Disease: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.11 Endometriosis
- 8.11.1 Overview
- 8.11.2 Endometriosis: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.12 Menstruation
- 8.12.1 Overview
- 8.12.2 Menstruation: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Middle East & Africa Hematuria Treatment Market Analysis – by Type
9.1 Macroscopic Hematuria
- 9.1.1 Overview
- 9.1.2 Macroscopic Hematuria: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Microscopic Hematuria
- 9.2.1 Overview
- 9.2.2 Microscopic Hematuria: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Idiopathic Hematuria
- 9.3.1 Overview
- 9.3.2 Idiopathic Hematuria: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.4 Jogger's Hematuria
- 9.4.1 Overview
- 9.4.2 Jogger's Hematuria: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Middle East & Africa Hematuria Treatment Market Analysis – by End User
10.1 Hospitals
- 10.1.1 Overview
- 10.1.2 Hospitals: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.2 Clinics
- 10.2.1 Overview
- 10.2.2 Clinics: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.3 Ambulatory Surgical Centers
- 10.3.1 Overview
- 10.3.2 Ambulatory Surgical Centers: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
11. Middle East & Africa Hematuria Treatment Market – Middle East and Africa Analysis
11.1 Overview
11.2 Middle East and Africa- 11.2.1 Middle East & Africa Hematuria Treatment Market Breakdown, by Key Country, 2022 and 2028 (%)
- 11.2.1.1 Middle East & Africa Hematuria Treatment Market – Revenue and Forecast Analysis – by Country
- 11.2.1.1 South Africa: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 South Africa: Middle East & Africa Hematuria Treatment Market Breakdown, by Treatment
- 11.2.1.1.2 South Africa: Middle East & Africa Hematuria Treatment Market Breakdown, by Indication
- 11.2.1.1.3 South Africa: Middle East & Africa Hematuria Treatment Market Breakdown, by Type
- 11.2.1.1.4 South Africa: Middle East & Africa Hematuria Treatment Market Breakdown, by End User
- 11.2.1.2 Saudi Arabia: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 Saudi Arabia: Middle East & Africa Hematuria Treatment Market Breakdown, by Treatment
- 11.2.1.2.2 Saudi Arabia: Middle East & Africa Hematuria Treatment Market Breakdown, by Indication
- 11.2.1.2.3 Saudi Arabia: Middle East & Africa Hematuria Treatment Market Breakdown, by Type
- 11.2.1.2.4 Saudi Arabia: Middle East & Africa Hematuria Treatment Market Breakdown, by End User
- 11.2.1.3 UAE: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 UAE: Middle East & Africa Hematuria Treatment Market Breakdown, by Treatment
- 11.2.1.3.2 UAE: Middle East & Africa Hematuria Treatment Market Breakdown, by Indication
- 11.2.1.3.3 UAE: Middle East & Africa Hematuria Treatment Market Breakdown, by Type
- 11.2.1.3.4 UAE: Middle East & Africa Hematuria Treatment Market Breakdown, by End User
- 11.2.1.4 Rest of Middle East and Africa: Middle East & Africa Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Hematuria Treatment Market Breakdown, by Treatment
- 11.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Hematuria Treatment Market Breakdown, by Indication
- 11.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Hematuria Treatment Market Breakdown, by Type
- 11.2.1.4.4 Rest of Middle East and Africa: Middle East & Africa Hematuria Treatment Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 AstraZeneca
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Bristol-Myers Squibb Company
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 F. HOFFMANN-LA ROCHE LTD.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 GlaxoSmithKline plc.
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Janssen Pharmaceuticals
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Merck & Co., Inc.
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Novartis AG
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Pfizer Inc.
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Sun Pharmaceutical Industries Ltd
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Boehringer Ingelheim International GmbH
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Access the Full M Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
